FR2654107A1 - Lipoamino acids with non-peroxidisable unsaturated fatty chains - Google Patents

Lipoamino acids with non-peroxidisable unsaturated fatty chains Download PDF

Info

Publication number
FR2654107A1
FR2654107A1 FR8914400A FR8914400A FR2654107A1 FR 2654107 A1 FR2654107 A1 FR 2654107A1 FR 8914400 A FR8914400 A FR 8914400A FR 8914400 A FR8914400 A FR 8914400A FR 2654107 A1 FR2654107 A1 FR 2654107A1
Authority
FR
France
Prior art keywords
methionine
acids
unsaturated fatty
lipoamino
lipoamino acids
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
FR8914400A
Other languages
French (fr)
Other versions
FR2654107B1 (en
Inventor
Morelle Jean
Lauzanne Eliane-Nee-Morelle
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Priority to FR8914400A priority Critical patent/FR2654107B1/en
Publication of FR2654107A1 publication Critical patent/FR2654107A1/en
Application granted granted Critical
Publication of FR2654107B1 publication Critical patent/FR2654107B1/en
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61QSPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00Preparations for care of the skin
    • A61Q19/08Anti-ageing preparations
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/40Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing nitrogen
    • A61K8/44Aminocarboxylic acids or derivatives thereof, e.g. aminocarboxylic acids containing sulfur; Salts; Esters or N-acylated derivatives thereof
    • A61K8/447Aminocarboxylic acids or derivatives thereof, e.g. aminocarboxylic acids containing sulfur; Salts; Esters or N-acylated derivatives thereof containing sulfur
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/64Proteins; Peptides; Derivatives or degradation products thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/64Proteins; Peptides; Derivatives or degradation products thereof
    • A61K8/65Collagen; Gelatin; Keratin; Derivatives or degradation products thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61QSPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q17/00Barrier preparations; Preparations brought into direct contact with the skin for affording protection against external influences, e.g. sunlight, X-rays or other harmful rays, corrosive materials, bacteria or insect stings
    • A61Q17/04Topical preparations for affording protection against sunlight or other radiation; Topical sun tanning preparations
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61QSPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q5/00Preparations for care of the hair
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C231/00Preparation of carboxylic acid amides
    • C07C231/22Separation; Purification; Stabilisation; Use of additives

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Birds (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Dermatology (AREA)
  • Gerontology & Geriatric Medicine (AREA)
  • Cosmetics (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

The invention relates to the preparation of lipoamino acid structures with unsaturated fatty chains, characterised in that they are not peroxidisable and cannot give rise to the formation of malondialdehyde, a marker for the oxidative process of biological aging. Such lipoamino acids with unsaturated fatty chains are obtained by the addition of methionine to the amino acids taken individually or in the form of mixtures before acylation with the unsaturated fatty chains.

Description

Contrairement aux structures lipoaminoacides comportant des chaines grasses saturées,les les structures à chaines insaturées sont douées d'une remarquable action émolliente, presentant de ce fait un intéret particulier pour toutes préparations destinées a ètre mises en contact avec la peau.In contrast to lipoamino acid structures having saturated fatty chains, the unsaturated chain structures have a remarkable emollient action, thereby presenting a particular interest for all preparations intended to be brought into contact with the skin.

Contrairement aux lipoaminoacides à chaines saturées stables, les structures à chaines insaturées sont instables et se dégradent du fait de leur sensibilité à l'oxygène, en donnant des peroydes, facteurs de vieillissement ( Plasma lipoperoxydes and yging-
Biomedicine 1982 36 164) et de la malondialdéhyde toxique.
Unlike stable saturated chain lipoamino acids, unsaturated chain structures are unstable and degrade due to their sensitivity to oxygen, giving peroyes, aging factors (Plasma lipoperoxides and yging-
Biomedicine 1982 36 164) and toxic malondialdehyde.

La présente invention a pour objet de réaliser des lipoaminoacides contenant des chai nets grasses insaturées, caractérisées en ce qu'ils comportent de 5 à 20 s de méthionine,par rapport aux acides aminés acylés,introduite dans le milieu réactionnel lors de l'acylation par un chlorure d'oléoyle ou autre chlorure d'acides gras insaturés.The object of the present invention is to provide lipoamino acids containing unsaturated fatty chai, characterized in that they contain from 5 to 20 sec of methionine, relative to the acylated amino acids, introduced into the reaction medium during the acylation by an oleoyl chloride or other unsaturated fatty acid chloride.

ii titre d'exemple non limitatif, en opérant comme suit un, on réalisera un oléoyl ou linoléoylcollasène qui > en émulsion ne se peroxydera pas et ne donnera pas lieu à la formatiion de MDA:
Connaissant la quantité de collagène mise en jeu lors de son hydrolyse totale (donnant une réaction biurétique négative) on introduit dans le milieu alcalin 5 à 20 de méthionine.On opère la condensation avec le chlorure d'acide en fonction de la teneur en acides ami nés totaux,parès acidification et purification on obtient ainsi un oléoyl ou linoléoylcollageno-méthionine qui ne pourra se peroxyder et qui ne pourra pas biosynthétiser la MPA.,ce qui n'est pas le cas pour l'oléyl ou le linoléoylcollagène sans addition de méthionine, qui se peroxydent, malgré une teneur moyenne de O,Soz 5 en méthionine dans le collagène, ce qui montre que la quantité de méthionine, détermine l'activité anti-superoxyde.
By way of nonlimiting example, by operating as follows one, an oleoyl or linoleoylcollasene which> in emulsion will not be peroxidated and will not give rise to the formation of MDA will be carried out:
Knowing the amount of collagen involved during its total hydrolysis (giving a negative biuretic reaction) is introduced into the alkaline medium 5 to 20 of methionine.On operates the condensation with the acid chloride depending on the content of amino acids In this way, an oleoyl or linoleoyl-collagen-methionine which can not be peroxidized and which will not be able to biosynthesize the MPA, is not the case for oleyl or linoleoyl collagen without the addition of methionine. , which peroxidize, despite an average content of O, Soz 5 in methionine in collagen, which shows that the amount of methionine, determines the anti-superoxide activity.

En utilisant les chlorures d'acides gras insaturés comme asents d'acylation; d'autres hydrolysats de protéines, telles; albumine, kératine, caseine etc, ou plus simplement des acides aminés;on obtiendra ainsi d'autres lipoaminoacides a chaines insaturées caractérisés par la présence de 5 à 20 de méthionine par rapport au poids des acides aminés mis en oeuvre,tous protégés de la peroxydation,se traduisant par l'absence de formation de malondialdéhyde.Using unsaturated fatty acid chlorides as acylation asents; other protein hydrolysates, such; albumin, keratin, casein etc., or more simply amino acids, thus obtaining other lipoamino acids with unsaturated chains characterized by the presence of 5 to 20 of methionine relative to the weight of the amino acids used, all protected from peroxidation , resulting in the absence of malondialdehyde formation.

L'expérimentation a montré:
Qu'une émulsion laissée à l'air et à la lumière solaire durant 21 iours,comportant 5 d'oléoylcollagène contenant 10 de méthionine incorporée au moment de l'acylation, conduisait à une absence totale de peroxydes,mais que 5 de méthionine par rapport aux acides aminés acylés étaient insuffisants, conduisant seulement qu'à 50 de protection.
The experiment showed:
That an emulsion left in the air and sunlight for 21 days, comprising oleoyl collagen containing 10 methionine incorporated at the time of acylation, led to a total absence of peroxides, but that 5% of methionine compared with Acyl amino acids were insufficient, leading only to 50% protection.

Qu'une émulsion comportant 5% d'oléoylcollagène, conservée en pot opaque, montrait après 30 jours, un indite de peroxyde de 4,3 avec un pic caractéristique de MDA. que l'addition de 150 ppm de BHT,ne ramenait cet indice qu'à 3,que la MDA était voisine de celle de l'oléoyl-collagène non protégé;tandis que l'émulsion témoin (sans oléoyl-collagène) et l'émulsion contenant de l'oléoylcollagène comportant 10% de méthionine par rapport aux acides ami nés acylés montraient une absence de peroxydes et de MDA. That an emulsion containing 5% oleoyl collagen, kept in an opaque pot, showed after 30 days, a peroxide indite of 4.3 with a characteristic peak of MDA. that the addition of 150 ppm of BHT only reduced this index to 3, that the MDA was close to that of the unprotected oleoyl-collagen, while the control emulsion (without oleoyl-collagen) and the The oleoyl collagen emulsion with 10% methionine relative to the acylated amino acids showed an absence of peroxides and MDA.

Qu'après 8 mois de conservation dans des pots opaques et prélèvements mensuels pour contrôles de l'évolution de l'indice de peroxydes en rapport avec la MDA on observe une forte augmentation de MDA dans l'émulsion comportant 5% d'oléoylcollagène qui ne comporte pas de méthionine.4ue l'addition de 150 ppm de BHT à l'émulsion contenant 5% d'oléoylméthionine ne réduit l'indice de peroxyde que de 40% avec un pic caractéristique de la MDA. Quant à l'oléoylcollagène comportant la méthionine, on constate un indice de peroxydes NUL avec absence de MDA qui,pour cette dernière donne la meme courbe spectrocolorimétrique que celle obtenue avec l'émulsionine, témoin ne comportant pas d'oléoylcollagène,
Qu'après 8 mois de conservation en tubes,on constate la disparition des indices de peroxydes dans les émulsions d'oléoyl et linoléoyl collagène, et dans ces me mes émulsions comportant le BHT,tandis que les pics de MDÀ sont pratiquement identiques.Ceci montrant que tous les peroxydes présents ont été transformés en MDÀ.Quant aux émulsions protégées par 10% de méthionine, les indices de peroxydes sont NULS avec ABSENCE de MDA.
That after 8 months of storage in opaque pots and monthly samples for controls of the evolution of the peroxides index in relation to the MDA, there is a strong increase of MDA in the emulsion containing 5% of oleoyl collagen which does not The addition of 150 ppm BHT to the 5% oleoylmethionine emulsion reduces the peroxide value by only 40% with a peak characteristic of MDA. As for the oleoylcollagen containing methionine, there is a NUL peroxides index with absence of MDA, which gives the same spectrocolorimetric curve as that obtained with emulsifier, a control containing no oleoyl collagen,
After 8 months of storage in tubes, the disappearance of the peroxide indices in the oleoyl and linoleoyl collagen emulsions, and in these my emulsions containing the BHT, while the peaks of MDA are practically identical. that all the peroxides present have been converted into MDA. As for the emulsions protected by 10% of methionine, the peroxide indices are NULS with ABSENCE of MDA.

D'autre part l'expérimentation a également montré que des émulsions comportant 10% d'huile de foi e de morue particulièrement riche en
MDA et d'huile d'olive vierge comportant de la MDA à une teneur moins élevée ,conservées 8 mois en tubes,protéQées par un oléoylcollagène contenant 50% de méthionine par rapport aux acides ami nés acylés conduisaient à la disparition non seulement des indices de peroxydes,mais a une diminution de plus de 90% de la MDA présente dans les huiles.
On the other hand, the experiment has also shown that emulsions containing 10% of fish oil and cod particularly rich in
MDA and virgin olive oil with lower MDA, stored for 8 months in tubes, protected by an oleoyl collagen containing 50% methionine compared to acylated amino acids, led to the disappearance of not only peroxides, but has a decrease of more than 90% of the MDA present in oils.

A titre d'exemples non limitatifs,on réalisera les compositions suivantes: l-Composition dermatologique (anti-inflammatoire)
Stéarate de glycérol 12
Alcool cétylique............................... 5
Glycérol.......................................10
Cléoylcollagène contenant 10 s de
méthionine acyl ée selon la technique
précisée 10
Conservateur (anti-sermes) qs
Eau qs 100
2-Composition pour le traitement de l'inflammation du tissu
conjonctif::
Stéarate de glycèrol 12
alcool cétylique polyoxyéthyléné.............. 6
Propylèneglycol...............................10 Oléoylhydroxyproline-méthionine
à 10% de méthionine acylée 5
Acide caprylylcollagénique.................... 0,5
Eau qs 100
3-Composition cosmétique pour la protection des radiations
solaires:
Stéarate de polyoxyéthylèneglycol....10
Alcool gras polyoxyéthyléné...................... 5
Palmitate d'isopropyle 10
Oléoylcollagéno-méthionine à ::30? de
méthionine acylée....................... 5
Acide caprylylcollagénique.............. 0,5
Eau qs 100
4-Composition "antivieillissante";
Excipient comme 1,2 ou 3
oléoylcollagéno-méthionine à 30% de
méthionine acylée..................... 2,5
Linoléoylprolino-méthionine à
10 s de méthionine acylée 1,25
Linoléoylhydroxyprolino-méthionine
à 20? de méthionine acylée........... 1,25
5-Composition pour l'entretien physiologique de la peau:
Excipient comme 1 1,2 ou 3
Oléoylcollagéno-méthionine ............. 2
Oléoylkératinométhionine................ 2 6-Composition capillaire:
Clécylkératino-méthionina...............1,0
Ethanol (vol ) :34
Eau ...................................65 7-Composition capillaire: :
Oléoylcollagénométhionate de
lysine 2
Ethanol (Vol ) 20
Eau qs 100
As non-limiting examples, the following compositions will be made: l-dermatological composition (anti-inflammatory)
Glycerol stearate 12
Cetyl alcohol ............................... 5
Glycerol ....................................... 10
Cloylcollagen containing 10 s of
methionine acylated according to the technique
specified 10
Conservative (anti-serms) qs
Water qs 100
2-Composition for the treatment of inflammation of the tissue
connective::
Glycerol stearate 12
polyoxyethylenated cetyl alcohol .............. 6
Propylene glycol ............................... Olleoylhydroxyproline-methionine
10% acylated methionine
Caprylylcollagenic acid .................... 0,5
Water qs 100
3-Cosmetic composition for radiation protection
solar Cells:
Polyoxyethylene glycol stearate .... 10
Polyoxyethylenated fatty alcohol ...................... 5
Isopropyl palmitate 10
Oleaoylcollageno-methionine at :: 30? of
acylated methionine ....................... 5
Caprylylcollagenic acid .............. 0,5
Water qs 100
4-Composition "anti-aging";
Excipient like 1,2 or 3
oleoylcollageno- methionine at 30%
acylated methionine ..................... 2,5
Linoleoylprolino-methionine
10 s of acylated methionine 1.25
Linoléoylhydroxyprolino-methionine
at 20? acylated methionine ........... 1.25
5-Composition for the physiological maintenance of the skin:
Excipient like 1, 2 or 3
Oleoylcollageno-methionine ............. 2
Oléoylkeratinomethionine ................ 2 6-Capillary composition:
Clécylkératino-méthionina ............... 1.0
Ethanol (vol): 34
Water ................................... 65 7-Hair Composition::
Oleoylcollagenomethionate
lysine 2
Ethanol (Vol) 20
Water qs 100

Claims (4)

- REVENDICATIONS 1- Lipoaminoacides comportant des chaînes grasses insaturées, caractérisés en ce qu'ils sont protégés de la peroxydation et de la formation de malondialdéhyde qui en est issue,par par le fait d'ajouter aux acides ami nés pris individuellement ou en mélange des quantités de méthionine variant entre 5 et 50 selon les destinations d'emplois. 1- Lipoamino acids containing unsaturated fatty chains, characterized in that they are protected from peroxidation and the formation of malondialdehyde which results therefrom, by the fact of adding to friendly acids taken individually or as a mixture of quantities of methionine varying between 5 and 50 depending on the job destinations. 2-Lipoaminoacides à chaines insaturées caractérisés en ce qu'ils ne peuvent se peroxyder et donner lieu à la formation de Malondialdé- des du fait que les procédés d'acylation connus sont appliqués aux acides aminés en mélange avec de la méthionine,dans les proportions indiquées selon la revendication 1.2-Lipoamino acids with unsaturated chains characterized in that they can not peroxidize and give rise to the formation of Malondialdeeds because the known acylation processes are applied to the amino acids mixed with methionine, in the proportions indicated according to claim 1. 3-Lipoaminoacides selon les revendications 1 et 2,caractérisés par des propriétés émollientes superieures aux corps gras végétaux et animaux,par l'absence de dégradation oxydative,par par la protection des lipides contre la dégradation oxydative et par l'apport d'une acidité biolosique en conformité avec la physiologie. 3-Lipoamino acids according to claims 1 and 2, characterized by emollient properties superior to vegetable and animal fats, by the absence of oxidative degradation, by the protection of lipids against oxidative degradation and by the provision of acidity biologic in accordance with physiology. 4-Lipoaminoacides à chaines insaturées,caractérisés selon les revendications 1,2 et 3,avantageusement utilisés dans la réalisation de toutes compositions destinéesà etre appliquées sur l'homme, l'animal ou le végétal. 4-Lipoamino acids with unsaturated chains, characterized according to claims 1,2 and 3, advantageously used in the production of any compositions intended to be applied to humans, animals or plants.
FR8914400A 1989-11-03 1989-11-03 LIPOAMINOACIDS WITH NON-PEROXIDABLE FATTY CHAINS. Expired - Lifetime FR2654107B1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
FR8914400A FR2654107B1 (en) 1989-11-03 1989-11-03 LIPOAMINOACIDS WITH NON-PEROXIDABLE FATTY CHAINS.

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR8914400A FR2654107B1 (en) 1989-11-03 1989-11-03 LIPOAMINOACIDS WITH NON-PEROXIDABLE FATTY CHAINS.

Publications (2)

Publication Number Publication Date
FR2654107A1 true FR2654107A1 (en) 1991-05-10
FR2654107B1 FR2654107B1 (en) 1995-03-31

Family

ID=9387040

Family Applications (1)

Application Number Title Priority Date Filing Date
FR8914400A Expired - Lifetime FR2654107B1 (en) 1989-11-03 1989-11-03 LIPOAMINOACIDS WITH NON-PEROXIDABLE FATTY CHAINS.

Country Status (1)

Country Link
FR (1) FR2654107B1 (en)

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2691065A1 (en) * 1992-05-18 1993-11-19 Morelle Jean New eye compositions intended for the prevention and treatment of certain vision disorders.
FR2747309A1 (en) * 1996-04-16 1997-10-17 Morelle Jean Compositions for treating burns and wounds with antimicrobial, anti-free radical and regenerating activity
CN109562043A (en) * 2016-07-27 2019-04-02 荷兰联合利华有限公司 Personal care composition comprising fatty acid amide derivant

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3290368A (en) * 1962-05-30 1966-12-06 Hoechst Ag Nu-sorboylamino acids
GB2200633A (en) * 1987-01-26 1988-08-10 Jean Morelle Antioxygen agents

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3290368A (en) * 1962-05-30 1966-12-06 Hoechst Ag Nu-sorboylamino acids
GB2200633A (en) * 1987-01-26 1988-08-10 Jean Morelle Antioxygen agents

Non-Patent Citations (3)

* Cited by examiner, † Cited by third party
Title
BIOLOGICAL ABSTRACTS, vol. 69, no. 4, résumé no. 27200, Philadelphia, PA, US; I. ANUNDI et al.: "Glutathione depletion in isolated hepatocytes: Its relation to lipid peroxidation and cell damage", & ACTA PHARMACOL. TOXICOL. 45(1): 45-51. 1979 *
CHEMICAL ABSTRACTS, vol. 95, no. 17, 26 octobre 1981, page 161, résumé no. 145123p, Columbus, Ohio, US; S. SHAW et al.: "Ethanol-induced lipid peroxidation: potentiation by long-term alcohol feeding and attenuation by methionine", & J. LAB. CLIN. MED. 1981, 98(3), 417-24 *
CHEMICAL ABSTRACTS, vol. 98, no. 21, 23 mai 1983, page 523, résumé no. 177739x, Columbus, Ohio, US; J. KANNER et al.: "Initiation of lipid peroxidation by a peroxidase hydrogen peroxide/halide system", & LIPIDS, 1983, 18(3), 204-10 *

Cited By (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2691065A1 (en) * 1992-05-18 1993-11-19 Morelle Jean New eye compositions intended for the prevention and treatment of certain vision disorders.
WO1993023028A1 (en) * 1992-05-18 1993-11-25 Jean Morelle Dipalmitoylhydroxyproline and oleoylmethionine containing composition
FR2747309A1 (en) * 1996-04-16 1997-10-17 Morelle Jean Compositions for treating burns and wounds with antimicrobial, anti-free radical and regenerating activity
CN109562043A (en) * 2016-07-27 2019-04-02 荷兰联合利华有限公司 Personal care composition comprising fatty acid amide derivant
US11202743B2 (en) 2016-07-27 2021-12-21 Conopco, Inc. Personal care compositions comprising fatty acid amide derivatives
CN109562043B (en) * 2016-07-27 2022-04-08 联合利华知识产权控股有限公司 Personal care compositions comprising fatty acid amide derivatives

Also Published As

Publication number Publication date
FR2654107B1 (en) 1995-03-31

Similar Documents

Publication Publication Date Title
EP1061895B1 (en) Synergetic composition comprising a compound with lipoaminoacid structure and a tuberous water-lily extract
LU84485A1 (en) NOVEL ANTI-ACNE COMPOSITION BASED ON BENZOYL PEROXIDE AND AT LEAST ONE OTHER ACTIVE INGREDIENT
FR2771632A1 (en) Cosmetic compositions containing N-acyl amino acid and 1,2-diol
FR2557452A1 (en) NOVEL COMPOSITIONS FOR SKIN CARE CONTAINING PRIMER OIL AND RATE TISSUE TRAITS
CA1199335A (en) Copper lanolate, and topical compositions containing same
FR2636238A1 (en) NEW ANTISUDORAL COMPOSITIONS
EP0998264A1 (en) Composition comprising a lipoaminoacid and a tannin-rich plant extract
FR2758984A1 (en) ACTIVE SYNERGISTIC COMPLEX AND COSMETIC AND / OR PHARMACEUTICAL PRODUCT COMPRISING THIS COMPLEX
EP0138262B1 (en) Composition for treatment of skin affections and its application
WO1997045101A1 (en) USE OF α-ALKYLGLUCOSIDES AND α-ALKYLGLUCOSIDE ESTERS AS ANTI-MICROBIAL EMULSIFYING AGENTS
EP0593506B1 (en) Lipoaminoacids, preparation method and applications
FR2654107A1 (en) Lipoamino acids with non-peroxidisable unsaturated fatty chains
FR2771633A1 (en) SYNERGISTIC COMPOSITION COMPRISING AT LEAST ONE N-OCTANYL AMINOACIDE AND AT LEAST ONE N-UNDECYLENOYL AMINOACIDE; COSMETIC APPLICATION
FR2622103A1 (en) Novel insect-repellent dermatological suntan compositions
FR2765105A1 (en) Cosmetic composition for e.g treating acne or hydrating skin and scalp
FR2604624A1 (en) New cosmetic or dermatological compositions that are rich in essential fatty acids present both in the form of triglycerides and in free or salified form
FR2543828A1 (en) NOVEL ANTI-ACNEIC COMPOSITION BASED ON TIOXOLONE AND AT LEAST ONE OTHER ACTIVE INGREDIENT
FR2555445A1 (en) Gel containing natural aloe: cosmetic composition with anti-acne and moisturising properties. Gel containing aloe vera Barbadensis Miller (product claimed)
FR2634120A1 (en) NEW COSMETIC COMPOSITIONS BASED ON CHROMONE-CARBOXYLATES
EP0520865A1 (en) Use of acid derivatives for the preparation of a pediculicidal medicament
FR2752421A1 (en) ANTI-SEBORRHEIC GUANIDINE SALTS
FR2756489A1 (en) Treatment of hyperkeratoses
FR2593023A1 (en) Composition and method for decreasing the aggressiveness of bees
JP6651104B1 (en) Method for producing external composition
RU94015249A (en) Cosmetic agent for skin ageing prevention

Legal Events

Date Code Title Description
TP Transmission of property